Literature DB >> 22886770

Second round robin for plasma hepcidin methods: first steps toward harmonization.

Joyce J C Kroot1, Antonius E van Herwaarden, Harold Tjalsma, Rob T P Jansen, Jan C M Hendriks, Dorine W Swinkels.   

Abstract

Measurements of the iron regulatory hormone hepcidin by various methodologies and laboratories are not harmonized. As a result different numeric results are obtained for the same clinical sample. We investigated whether better agreement between plasma hepcidin methods can be achieved by harmonization. Native plasma pools (n = 11) of a variety of hepcidin concentrations and blank plasma spiked with three different quantities of synthetic hepcidin-25 purchased from two different commercial sources (n = 6), were distributed in duplicate among 21 methods worldwide. We assessed commutability by comparing results from synthetic hepcidin with those from native samples in various method couples by Bland-Altman plots. Methods differed substantially in absolute values and reproducibility. For the majority of methods we found that samples with synthetic hepcidin-25 were noncommutable with the native samples. In an attempt to harmonize by using native hepcidin results, we selected two methods that showed good mutual agreement of native results and calculated consensus values as the medians for the 11 duplicate native samples obtained by these two methods. Finally, we constructed algorithms enabling the laboratories to calculate the hepcidin consensus (HEPCON) value using their own native hepcidin results. We found that the use of these algorithms substantially reduced the between-method CV. Until commutable materials are defined, hepcidin harmonization can be achieved by exploiting specific algorithms, allowing each lab to report their native hepcidin concentrations in HEPCON values. This study represents the first step toward harmonization of plasma hepcidin methods and facilitates aggregation of hepcidin data from different research investigations.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886770     DOI: 10.1002/ajh.23289

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  23 in total

Review 1.  Modulation of hepcidin to treat iron deregulation: potential clinical applications.

Authors:  Nicole L Blanchette; David H Manz; Frank M Torti; Suzy V Torti
Journal:  Expert Rev Hematol       Date:  2015-12-15       Impact factor: 2.929

Review 2.  Perspective: What Makes It So Difficult to Mitigate Worldwide Anemia Prevalence?

Authors:  Klaus Schümann; Noel W Solomons
Journal:  Adv Nutr       Date:  2017-05-15       Impact factor: 8.701

3.  The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study.

Authors:  Antonio Macciò; Clelia Madeddu; Giulia Gramignano; Carlo Mulas; Luciana Tanca; Maria Cristina Cherchi; Carlo Floris; Itaru Omoto; Antonio Barracca; Tomas Ganz
Journal:  Haematologica       Date:  2014-09-19       Impact factor: 9.941

4.  Circulatory hepcidin is associated with the anti-inflammatory response but not with iron or anemic status in childhood malaria.

Authors:  Florence Burté; Biobele J Brown; Adebola E Orimadegun; Wasiu A Ajetunmobi; Nathaniel K Afolabi; Francis Akinkunmi; Olayinka Kowobari; Samuel Omokhodion; Kikelomo Osinusi; Felix O Akinbami; Wuraola A Shokunbi; Olugbemiro Sodeinde; Delmiro Fernandez-Reyes
Journal:  Blood       Date:  2013-02-04       Impact factor: 22.113

5.  Efficacy and safety of deferasirox in non-thalassemic patients with elevated ferritin levels after allogeneic hematopoietic stem cell transplantation.

Authors:  N Jaekel; K Lieder; S Albrecht; O Leismann; K Hubert; G Bug; N Kröger; U Platzbecker; M Stadler; K de Haas; S Altamura; M U Muckenthaler; D Niederwieser; H K Al-Ali
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

Review 6.  Pathophysiology of Iron Homeostasis during Inflammatory States.

Authors:  Bobby J Cherayil
Journal:  J Pediatr       Date:  2015-10       Impact factor: 4.406

Review 7.  Iron refractory iron deficiency anemia.

Authors:  Luigia De Falco; Mayka Sanchez; Laura Silvestri; Caroline Kannengiesser; Martina U Muckenthaler; Achille Iolascon; Laurent Gouya; Clara Camaschella; Carole Beaumont
Journal:  Haematologica       Date:  2013-06       Impact factor: 9.941

Review 8.  Modern iron replacement therapy: clinical and pathophysiological insights.

Authors:  Domenico Girelli; Sara Ugolini; Fabiana Busti; Giacomo Marchi; Annalisa Castagna
Journal:  Int J Hematol       Date:  2017-12-01       Impact factor: 2.490

9.  Serum hepcidin in infants born after 32 to 37 wk of gestational age.

Authors:  Lieke Uijterschout; Magnus Domellöf; Staffan K Berglund; Micky Abbink; Paul Vos; Lyanne Rövekamp; Bart Boersma; Carina Lagerqvist; Cisca Hudig; Johannes B van Goudoever; Frank Brus
Journal:  Pediatr Res       Date:  2015-12-16       Impact factor: 3.756

Review 10.  Hepcidin in the diagnosis of iron disorders.

Authors:  Domenico Girelli; Elizabeta Nemeth; Dorine W Swinkels
Journal:  Blood       Date:  2016-04-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.